Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 2,615 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sleep-Wake Disorders Clear all

Conditions: Sleep Apnea, Obstructive, Sleep Apnea Syndromes, Child Behavior Disorders, Attention Deficit Disorder With Hyperactivity, Disorders of Excessive Somnolence
Interventions: CPAP treatment, No CPAP treatment; Procedure · Other
Lead sponsor: University of Michigan; Other
Eligibility: 5 Years to 12 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Ischemic Stroke, Obstructive Sleep Apnea
Interventions: PAP, HLE; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Sleep Wake Disorders
Interventions: PUSH text messages, PULL text messages, TranS-C, PE; Other · Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 10 Years to 18 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Cognitive Behavioral Therapy, Sleep Initiation and Maintenance Disorders, Sleep Deprivation, Sleep Disorders, Intrinsic
Interventions: firefighter Sleep Health Coaching Intervention (ffSHC), Control (Minimally Enhanced Usual Care); Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: ESRD, Sleep Apnea, Oxygen Deficiency
Interventions: Observational; Other
Lead sponsor: Renal Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy, Narcolepsy Type 2, Narcolepsy Without Cataplexy
Interventions: Imagery rehearsal therapy, Targeted dream control; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Apnea, Obstructive Sleep Apnea (OSA), Obesity
Interventions: Restriction, Extension; Other
Lead sponsor: University of Chicago; Other
Eligibility: 25 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Insomnia, Suicide
Interventions: Behavioral Activation for Depression, Cognitive Behavior Therapy for Insomnia, Collaborative Assessment and Management of Suicidality, Care-as-Usual Psychotherapy; Behavioral
Lead sponsor: Evidence-Based Practice Institute, Seattle, WA; Industry
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Insomnia
Interventions: E2006; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Obstructive Sleep Apnea
Interventions: TPAP, CPAP; Other · Device
Lead sponsor: SleepRes Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Clarksville, Tennessee

Conditions: Idiopathic Hypersomnia, Narcolepsy Without Cataplexy
Interventions: BTD-001, Placebo; Drug
Lead sponsor: Balance Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 23
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 19 more

Conditions: Sleep Apnea
Interventions: Standard of Care, Personalized OSA Treatment; Other · Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 55 Years to 85 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Rett Syndrome, Prader-Willi Syndrome, Angelman Syndrome, Sleep Problems
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Year to 18 Years
Enrollment: 804 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Birmingham, Alabama • Irvine, California • San Diego, California + 6 more

Conditions: Sleep Initiation and Maintenance Disorders, Circadian Rhythm Sleep Disorders, Hypersomnia
Interventions: light exposure; Procedure
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Disorder, Restless Legs Syndrome
Interventions: Istradefylline (KW-6002); Drug
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Parkinson Disease, REM Behavior Disorder
Interventions: Sleep, PD and DBS; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Primary Insomnia
Interventions: Eplivanserin, Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Pregnancy, Postpartum Period, Sleep Disturbance
Interventions: Sleep hygiene, Dietary information, Acetaminophen; Behavioral · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Shift-Work Sleep Disorder, Shift-Work Related Sleep Disturbance
Interventions: 8-h Afternoon-Evening Sleep, 8-h Free Sleep; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Hyperactivity Disorder, Child, Preschool, Sleep, Sleep Disturbance
Interventions: Brief Parent Behavioral Intervention, Sleep-Focused Parent Behavioral Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 3 Years to 5 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Cranberry Township, Pennsylvania • Monroeville, Pennsylvania • New Castle, Pennsylvania + 1 more

Conditions: Insomnia, Posttraumatic Stress Disorder
Interventions: suvorexant, placebo; Drug · Other
Lead sponsor: Howard University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Sleep Apnea, Obstructive
Interventions: CPAP + Peer Support, CPAP + Individual Education; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Substance Withdrawal Syndrome
Interventions: Melatonin, Matched Placebo; Dietary Supplement
Lead sponsor: Duquesne University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Parkinson Disease, Sleep Disorder, Fatigue
Interventions: SunRay Light Boxes; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 25
States / cities: Birmingham, Alabama • Phoenix, Arizona • Irvine, California + 20 more

Search by objective public record fields.

Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children

The Recovery in Stroke Using PAP Study

Improving Memory for Sleep Treatment Content With Text Messages

Evaluating Worksite Sleep Health Coaching in Firefighters: The Sleep Assistance for Firefighters Study

Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis

Narcolepsy Nightmare Study

Predictors of the Metabolic Effect of Sleep Loss

PracticeGround: Transforming Training and Delivery of Mental Health EBPs

Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations

TheraPAP Equivalence Crossover Study

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW

Light Exposure to Treat Sleep Disruption in Older People

Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

Subcortical Oscillations in Human Sleep Dysregulation

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Sleep Disruption in New Mothers: An Intervention Trial

Sleep and Circadian Treatments for Shift Workers

Optimizing Attention and Sleep Intervention Study

Suvorexant and Trauma Related Insomnia

Group-based Peer Support Versus Individual Education for Patients Undergoing CPAP Treatment

The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program

Light Therapy for PD - Dose Selection